ViewPoint Therapeutics

About:

ViewPoint Therapeutics is a developer of crystallin stabilizers intended to prevent and treat cataracts and presbyopia.

Website: http://www.viewpointtherapeutics.com/

Top Investors: Mission BioCapital, The Rise Fund, Biotechnology Value Fund, Asset Management Ventures (AMV), Lagunita BioSciences

Description:

ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. The company's crystallin stabilizers include a small molecule that is active in preclinical models of age-related cataracts via a target-based screening and optimization effort, providing physicians with drugs to prevent or reverse protein misfolding, which is implicated in numerous common disorders of aging including cataracts, presbyopia, and neurodegenerative diseases.